Context.-Although concern over the risks of red blood cell transfusion has resulted in several practice guidelines for transfusion, lack of data regarding the physiological effects of anemia in humans has caused uncertainty regarding the blood hemoglobin (Hb) concentration requiring treatment.
THE MOST COMMON indication for the transfusion of red blood cells is to augment the oxygen-carrying capacity of the blood of an anemic patient. The potential for blood components to transmit infectious disease has produced concern and "guidelines," "practice parameters," or "standards" delineating conditions under which it is appropriate to transfuse red blood cells. [1] [2] [3] [4] Formulation of these documents has been hindered by the lack of data defining the hemoglobin (Hb) concentration in humans that does not allow for adequate oxygen transport (TO 2 ) and that initiates tissue hypoxia.
Accordingly, we acutely decreased the Hb concentration of 32 healthy resting humans to test the hypothesis that a blood Hb concentration of 50 g/L would result in tissue hypoxia secondary to inadequate TO 2 .Wedidnotconductthesestudieswith the subjects performing any activity that would thereby increase oxygen consumption (V O 2 ). Consequently, our results are applicable only to humans at rest.
METHODS
With approval of our institutional review board and with informed consent, we studied 11 patients before a surgical procedure with an anticipated blood loss of 2 L or more and 21 paid volunteers not undergoing surgery. Data from patients were collected before anesthesia and surgery. All volunteers and patients were without cardiovascular, pulmonary, or hepatic disease; did not smoke; and were not taking any drugs with cardiovascular actions.
Peripheral venous, radial arterial, and flow-directed pulmonary arterial (via the right internal jugular vein; Baxter Healthcare, Glendale, Calif) cannulas were inserted into each subject using local anesthesia. In 18 subjects an intravenous infusion of propofol (50-150 micrograms per kilogram per minute [µg·kg ]) provided mild sedation during the introduction of the pulmonary artery cannula. Following insertion of the cannulas, subjects rested for 30 minutes prior to measurement of variables. Intra-arterial, central venous, pulmonary arterial, and pulmonary capillary wedge pressures and heart rate were measured. Cardiac output (duplicate or triplicate if duplicates differed by more than 10%, by thermodilution; A/ S3 Datex Medical Instrumentation, Tewksbury, Mass) was recorded before removal of any blood, and 5 to 10 minutes after isovolemic removal of each 450 to 900 mL of blood into collection bags (CPDA-1 collection bags, Baxter Healthcare Corp, Deerfield, Ill). Removal of each 450 mL of blood took approximately 10 minutes. Isovolemia was maintained by intravenous infusion of 5% human serum albumin (Baxter Healthcare, Glendale, Calif) and/or the subject's own platelet-rich plasma (after separation from the red blood cells of the removed blood). These were infused simultaneously with blood removal, in quantities approximately equal to that of the removed blood, to maintain constant central venous and pulmonary capillary wedge pressures. At the time of cardiovascular measurements, arterial and mixed venous blood was sampled for measurement of pH, oxygen content, and oxyhemoglobin saturation (OSM3 Hemoximeter, Radiometer, Copenhagen, Denmark) and arterial lactate concentration (Yellow Springs Instrument Co, YSI No. 2700, Yellow Springs, Ohio). Stroke volume index, systemic vascular resistance index, TO 2 , and V O 2 were calculated by standard formulas. The subjects' pulmonary artery temperature was maintained at 37°C by body surface warming with heated air and by warming the infused fluids. The electrocardiogram (ECG; 5-lead in all subjects) was monitored and a 3-channel Holter ECG in 21 of the 32 subjects (3 patients and 18 volunteers) (Del Mar model 459, Del Mar Avionics, Irvine, Calif) was recorded continuously from 1 hour before through the completion of the study. The frequency response of the Holter recorder met the American Heart Association specification for ST changes, the cutoff limit being 0.05 Hz for low frequency and 100 Hz for high frequency. For Holter monitoring, 3 bipolar leads-CC5, modified CM5, and ML-were used. 5 Each ECG recording on Holter tapes was scanned visually using an ECG analysis system (Del Mar model 750). All normal QRS complexes were identified, and all abnormal QRS complexes (eg, ventricular ectopic beats and conduction abnormalities) were excluded from ST-segment analysis. Continuous ST-segment trends were generated for the entire tape. All possible ischemic episodes were reviewed and verified by an investigator who was blinded to patient identity and Hb concentration. An ischemic episode was defined as a reversible ST-segment shift from baseline of 0.1 mV or greater depression at J + 60 msec, or 0.2 mV or greater elevation at the J point lasting for at least 1 minute. The time after the J point chosen to measure ST-segment depression was adjusted to exclude T wave during tachycardia.
The 2 . Because the number of measurements of TO 2 for each individual ranged from 5 to 11, the number of values that could be used to fit each of the 2 linear regressions would be small. Therefore, we applied a method of analysis-mixedeffects modeling-in which data for all subjects are analyzed simultaneously, accounting for interindividual differences in such covariates as age and sex; the analysis accounts for the repeated-measures nature of the data (NONMEM with the NONMEM program, Version V, Level 1.0L4 7 ). The model contained 4 parameters, each of which was estimated: Hb i , TO 2 (Hb i ), slope(Hb Ͼ Hb i ), and slope (Hb Ͻ Hb i ). For the first 3 of these parameters, interindividual variability was assumed to be log-normally distributed. To permit the fourth parameter to be either positive or negative, interindividual variability was modeled as normally distributed. Residual error between observed and measured values for TO 2 was assumed to have a constant variance (ie, measurement error in TO 2 did not vary with Hb). After each population fit was complete, we used NONMEM's post hoc step to obtain Bayesian estimates of the parameters for each individual; these Bayesian estimates were plotted against each of age, weight, sex, and body surface area to assess whether these covariates influenced the parameters. Goodness of fit was assessed by inspection of the fit of the population and Bayesian regression lines to the data for each individual and by NONMEM's objective function, − 2 log likelihood. Initially, we tested a model in which the "typical" values of the 4 parameters were the same for all subjects. Bayesian estimates suggested that Hb i varied with age. Permitting Hb i to vary with age improved the fit. Bayesian estimates from this model suggested that Hb i differed between men and women. Incorporating this into the model further improved the fit (both by visual inspection and by an improvement in NONMEM's objective function). Bayesian estimates now suggested that slope (Hb Ͻ Hb i ) varied with age. Permitting slope (Hb Ͻ Hb i ) to vary continuously with age did not improve the quality of the fit; however, permitting slope (Hb Ͻ Hb i ) to differ between those younger and those older than 30 years of age markedly improved the fit (again, both by visual inspection and by an improvement in NONMEM's objective function). Bayesian estimates from this model no longer suggested a relationship between the covariates and the parameters.
For illustrative purposes (Figures) and to quantify the response of each variable to the reduction in Hb concentration, data were grouped by Hb concentration increments of 10 g/L. To determine the influenceofsubjectageandsexontheresponse to acute isovolemic anemia, we performed a 2-way repeated-measures analysis of variance. Unless otherwise specified, all data are reported as mean (SE). Statistical significance was accepted at PՅ.05.
RESULTS
Patients were older and of greater weightandbodysurfaceareathanthevolunteers; there was no difference in initial Hb concentration or sex proportion between the 2 groups (Table 1 ). The dura- Figure 2 , PϽ.001). The relationship of heart rate to Hb concentration for each subject is depicted in Figure 3 .
The increase in cardiac index compensated for the decreased arterial oxygen content, maintaining TO 2 until Hb concentration decreased to a value (Hb i ) that depended on age and sex (as determined by population analysis). At Hb concentrations above Hb i the slope of the relationship was ϫ 0.669 milliliters of oxygen per kilogram per minute (mL O 2 ·kg Although TO 2 decreased at the lowest Hb concentrations, V O 2 increased slightly (Table 2, Figure 5 , PϽ.001). Plasma lactate concentration did not change (Table 2, Figure 6 , P=.09); arterial blood pH and base excess increased slightly (Table 2 , PϽ.001). There was no relationship between V O 2 and TO 2 in any subject.
No ST changes were observed in the online monitored ECG. Eighteen of the 21 Holter tapes could be analyzed completely. There were 2 brief episodes that met the criteria for significant ST changes. One episode was for 10 minutes in a 27-year-old woman when her Hb concentration was 62 g/L when she was sitting to urinate. Her TO 2 , unchanged from her baseline. These changes resolved at an Hb concentration of 46 g/L when her heart rate slowed from 110 to 89 beats per minute (with administration of esmolol, administered after the data reported here were collected, as part of a separate protocol in a subset of these subjects). The decrease in heart rate reduced TO 2 to 8. . At the lowest Hb concentrations many subjects reported fatigue but no other symptoms referable to decreased TO 2 or hypoxia.
Sex had no influence except for women having a lesser stroke volume index (P=.017) (and a lower Hb concentration at which TO 2 decreased; see above). Older subject age was associated with a higher mean arterial blood pressure (P=.007) (and a higher Hb concentration at which TO 2 decreased; see above). However, since our patients were older than the volunteers, it was not possible to determine whether these effects related to age or population.
COMMENT
The major finding of this study is that acute reduction of blood Hb concentration to 50 g/L in conscious healthy resting humans does not result in detectable inadequate systemic TO 2 . The systemic markers we used to detect consequences of inadequate TO 2 (V O 2 and plasma lactate concentration) did not demonstrate inadequate TO 2 with decreased Hb concentration. The lack of significantly increased plasma lactate in any of the 32 subjects indicates, with a 95% assurance, that acute reduction of Hb concentration to 50 g/L would not produce lactic acidemia in more than 9% of the population. 8 It would appear that the ST findings in the sitting subject were likely related to body position. We were unable to determine if the 0.11-mV ST change in the second subject was related to heart rate per se or to heart rate-induced myocardial ischemia. Based on data from acutely anemic conscious dogs, reducing heart rate from 110 to 89 beats per minute would decrease myocardial V O 2 by approximately 22%.
9,10 If we accept an incidence of 1 in 18, ST changes would not be expected to occur (with 95% assurance) in more than 16% of the population (incidence + 2 times the SE of the proportion). With an incidence of zero in 18, ST changes, with 95% assurance, would not be expected to occur in more than 15% of the population. 8 Our data are consistent with those obtained in conscious dogs 10 and baboons.
11
Acute reduction of hematocrit to 0.10 to 0.15 in conscious resting dogs and to 0.15 in conscious restrained baboons produced cardiovascular effects similar to those we observed in humans (decreased systemic vascular resistance; increased heart rate, stroke volume [dogs, but not baboons], and cardiac index), without change in V O 2 . 10, 11 The decreased systemic vascular resistance is, in part, related to the decreased blood viscosity 12 and, in part, to increased cross-sectional area of the vascular bed. We accomplished intravascular dilution with albumin and plasma so that altered viscosity in our subjects resulted solely from the decreased red cell concentration.
In our subjects, increased heart rate contributed approximately 75% and increased stroke volume approximately 25% of the increased cardiac output. These values are similar to those of 69% and 31%, respectively, in acutely anemic conscious dogs. 10 Inadequate TO 2 results in an inability to sustain V O 2 . Our subjects actually increased their V O 2 by approximately 14% at an Hb concentration of 50 g/L. This is likely due to the increased heart rate and/or sympathetic stimulation. If the relationship between myocardial V O 2 and heart rate during acute anemia is similar to that of the dog, 9,10 increased myocardial V O 2 accounted for approximately one fourth of our measured increased systemic V O 2 . Our result is consistent with the finding by Cain 13 of a small increase in the V O 2 of anesthetized dogs, at a hematocrit just above that which decreased V O 2 (hematocrit approximately 0.10). We found that TO 2 was maintained at Hb concentrations of at least 65 g/L for a 20-year-old woman and 92 g/L for a 20-year-old man. These values increased with increasing subject age. Our finding differs from that in conscious dogs of a linear decrease in TO 2 with decreasing Hb concentration. 10 The decreased TO 2 , however, does not imply inadequate delivery of oxygen to tissues.
Cain defined the "critical" TO 2 as that which is inadequate to prevent a decrease in V O 2 . 13 The Hemoglobin, g/L Heart Rate, beats per minute . Nevertheless, we did not find evidence of systemic acidosis in any subject. The slight increases of arterial blood pH and base excess were likely a result of the infused citrate anticoagulant (contained within the plasma). The electrocardiographic ST changes in 1 subject could have been related to heart rate or could have represented transient myocardial ischemia. Although we used a standard measure of myocardial ischemia that provides continuous measurement and printed availability for validation, 23 it remains possible that some episodes of ischemia might not have been detected. 24 "Guidelines," "standards," and "practice parameters" have suggested that patients without cardiovascular or pulmonary disease need not be given red blood cell transfusion unless their Hb concentration is less than 70 g/L 1 or 60 g/L. 3 The development of these documents and the advice they contain has been hampered by limited human data on which the authors and committees could rely. Our data support these recommendations and suggest that in healthy resting patients not taking drugs with cardiovascular actions, even lower Hb concentrations are tolerated without apparent adverse metabolic sequelae. We were unable to determine the critical Hb value in our healthy subjects, and thus cannot provide a definitive Hb concentration likely to require red blood cell transfusion. However, the human critical value for TO 2 is less than 10 mL O 2 ·kg −1 · min −1 , a level reached in normal humans at an Hb concentration of 50 g/L. Our subjects were studied supine, at rest. Thus, our results should not be extrapolated to circumstances of increased V O 2 (eg, activity), decreased ability to increase cardiac output (eg, cardiac disease, medications), or decreased ability to increase specific organ or tissue blood flow (eg, arterial stenosis). 
